HEALTHJun 16 · 16:19 UTCEURACTIVEmma Pirnay

EU health chief says Brussels studying impact of Trump’s drug pricing threats

The EU health chief stated that Brussels is studying the impact of Trump’s drug pricing threats. Capitals are seeking clarity on which medicines could be affected.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

EU health chiefpersonDonald TrumppersonDrug pricingtopiccapitalstopicMedicinestopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 2 · 13:25 UTC
STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
HEALTHMay 17 · 23:01 UTC
Campaigners threaten legal action over UK-US deal on prices NHS pays for drugs
HEALTHMay 28 · 08:30 UTC
STAT+: Trump’s drug-pricing deals set to be tested by new product launches
HEALTHJun 6 · 04:00 UTC
AstraZeneca chief warns group could withhold new drugs in Europe
HEALTHJun 10 · 08:30 UTC
STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices